Literature DB >> 31776613

[Current developments in dermatopharmacology].

Hans F Merk1, Johannes Wohlrab2,3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31776613     DOI： 10.1007/s00105-019-04508-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  7 in total

1.  Ligelizumab for Chronic Spontaneous Urticaria.

Authors:  Marcus Maurer; Ana M Giménez-Arnau; Gordon Sussman; Martin Metz; Diane R Baker; Andrea Bauer; Jonathan A Bernstein; Randolf Brehler; Chia-Yu Chu; Wen-Hung Chung; Inna Danilycheva; Clive Grattan; Jacques Hébert; Constance Katelaris; Michael Makris; Raisa Meshkova; Sinisa Savic; Rodney Sinclair; Karl Sitz; Petra Staubach; Bettina Wedi; Jürgen Löffler; Avantika Barve; Kenneth Kobayashi; Eva Hua; Thomas Severin; Reinhold Janocha
Journal:  N Engl J Med       Date:  2019-10-03       Impact factor: 91.245

2.  Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.

Authors:  Mark M Neis; Bettina Peters; Alexandra Dreuw; Joerg Wenzel; Thomas Bieber; Cornelia Mauch; Thomas Krieg; Sven Stanzel; Peter C Heinrich; Hans F Merk; Andreas Bosio; Jens M Baron; Heike M Hermanns
Journal:  J Allergy Clin Immunol       Date:  2006-09-01       Impact factor: 10.793

Review 3.  Translational drug discovery and development with the use of tissue-relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy.

Authors:  Peter Florian; Klaus R Flechsenhar; Eckart Bartnik; Danping Ding-Pfennigdorff; Matthias Herrmann; Paul J Bryce; Frank O Nestle
Journal:  Exp Dermatol       Date:  2019-06-11       Impact factor: 3.960

4.  Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis.

Authors:  Joerg Wenzel; Bettina Peters; Sabine Zahn; Michael Birth; Kay Hofmann; Daniel Küsters; Stefan Tomiuk; Jens M Baron; Hans F Merk; Cornelia Mauch; Thomas Krieg; Thomas Bieber; Thomas Tüting; Andreas Bosio
Journal:  J Invest Dermatol       Date:  2007-08-16       Impact factor: 8.551

Review 5.  The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin Disorders.

Authors:  Thomas Haarmann-Stemmann; Charlotte Esser; Jean Krutmann
Journal:  J Invest Dermatol       Date:  2015-08-13       Impact factor: 8.551

Review 6.  Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.

Authors:  Matthew Moyle; Ferda Cevikbas; Jamie L Harden; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2019-04-15       Impact factor: 3.960

7.  Old King coal - molecular mechanisms underlying an ancient treatment for atopic eczema.

Authors:  W H Irwin McLean; Alan D Irvine
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.